Mechanistic study on aniline-induced erythrocyte toxicity

Arhiv za Higijenu Rada i Toksikologiju

Volumn 58, Issue 3, 2007, Pages 275-285

  Singh, Harpal ^a,b   Purnell, Elissa ^a   Smith, Carion ^a  

^a SAVANNAH STATE UNIVERSITY   (United States)

^b SSU   (United States)

Author keywords

Cytoskeletal proteins; Hemolytic anemia; Hemotoxicity; Methemoglobin; Para bromo PHA; Para fluoro PHA; Para iodo PHA; Phenylhydroxylamine

Indexed keywords

ANILINE; BIOLOGICAL MARKER; BUFFER; CHROMIUM 51; GLUTATHIONE; HYDROXYLAMINE; MEMBRANE PROTEIN; METHEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CHEMICAL STRUCTURE; CIRCULATION; CONTROLLED STUDY; CYTOSKELETON; DISEASE MARKER; DOSE RESPONSE; DRUG SAFETY; ERYTHROCYTE; ERYTHROCYTE GHOST; HEMOLYTIC ANEMIA; MALE; METHEMOGLOBINEMIA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOACTIVITY; RAT; SPECTROPHOTOMETRY;

ANEMIA, HEMOLYTIC; ANILINE COMPOUNDS; ANIMALS; ERYTHROCYTES; GLUTATHIONE; HEMOLYSIS; MALE; METHEMOGLOBIN; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 35148867865     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10004-007-0018-2     Document Type: Article

References (45)

1. Grossman SJ, Jollow DJ. Role of dapsone hydroxylamines in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther 1988;244:118-25.
2. Reider MJ, Uetrecht J, Shear NH, Spielberg SP. Synthesis and in vitro toxicity if hydroxylamine metabolites of sulfonamides. J Pharmacol Exp Ther 1988;244: 724-8.
3. Coleman MD, Breckenridge AM, Park BK. Bioactivities of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Br J Clin Pharmacol 1989;28:389-95.
4. Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab Dispos 1991;19:900-6.
5. Jensen CB, Jollow DJ. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol 1991;111:1-12.
6. McMillan DC, Bradshaw TP, Hinson JA, Jollow DJ. Role of metabolites in propanil-induced hemolytic anemia. Toxicol Appl Pharmacol 1991;110:70-8.
7. Jollow DJ, Bradshaw TP, McMillan DC. Dapsone-induced hemolytic anemia. Drug Metab Rev 1995;27:107-24.
8. Bolchoz LJC, Budinsky RA, McMillan DC, Jollow DJ. Primaquine -induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther 2001;297:509-15.
9. Grossman SJ, Simson J, Jollow DJ. Dapsone-induced hemolytic anemia: Effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicol Appl Pharmacol 1992;117:208-17.
10. McMillan DC, Simson JV, Budinsky RA, Jollow DJ. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes. J Pharmacol Exp Ther 1995;274:540-7.
11. Bolchoz LJC, Morrow JD, Jollow DJ, McMillan DC. Primaquine -induced hemolytic anemia: effect of 6-Methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfydrayl status, membrane lipids, cytoskeletal proteins and morphology. J Pharmacol Exper Ther 2002;303:141-8.
12. Bowman ZS, Oatis JE Jr., Whelan JL, Jollow DJ, McMillan DC. Primaquine -induced hemolytic anemia: susceptibility of normal vs. glutathione-depleted rat erythrocytes to 5-hydroxylprimaquine. J Pharmacol Exp Ther 2004;309:79-85.
13. McMillan DC, Bolchoz LJ, Jollow DJ. Favism: Effect of divicine on rat erythrocyte sulfydryl status, hexose monophosphate shunts activity, morphology and membrane skeletal proteins. Toxicol Sci 2001;62:353-9.
14. Harrison JH Jr., Jollow DJ. Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther 1986;238:1045-54.
15. Harrison JH Jr., Jollow DJ. Contribution of aniline metabolites to aniline-induced methemoglobin. Mol Pharmacol 1987;32:423-31.
16. Henderson RF. Laboratory perspectives: finding a biomarker is a first stepm. In: Symposium "Biomarkers - The Genome and the Individual"; 4-8 May 1997; Charleston (SC), USA. Book of Abstracts. p. 11.
17. Cohen CM. The molecular organization of the red blood cell membrane skeleton. Semin Hematol 1983;20:141-58.
18. Knowles W, Marchesi SL, Marchesi VT. Spectrin: structure, function and abnormalities. Semin Hematol 1983;20:159-74.
19. Sheetz MP. Membrane skeletal dynamics: role in modulation of red cell deformability, mobility of transmembrane proteins, and shape. Semin Hematol 1983;20:175-88.
20. Mohandas N, Chasis JA, Shohet, SB. The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol 1983;20:225-42.
21. Marchesi VT. Stabilizing infrastructure of cell membranes. Ann Rev Cell Biol 1985;1:531-61.
22. Haest CW, Fischer TM, Plasa G, Deuticke B. Stabilization of erythrocyte shape by a chemical increase in membrane shear stiffness. Blood Cells 1980;6:539-53.
23. Palek J, Liu PA, Liu SC. Polymerisation of red cell membrane protein contributes to spheroechinocyte shape irreversibility. Nature 1978;274:505-7.
24. Bjerrum OJ, Hawkins M, Swanson P, Griffin M, Lorand L. An immunochemical approach for the analysis of membrane protein alterations in Ca+-loaded human erythrocytes. J Supramol Struct Cell Biochem 1981;16:289-301.
25. Lorand L, Siefring GE Jr., Lowe-Krentz L. Formation of gamma-glutamly-epsilon-lysin-bridges between membrane proteins by ca+-regulated enzyme in intact erythrocytes. J Supramol Struct 1978;9:427-40.
26. Smith BD, La Celle PL, Siefring G Jr., Lowe-Krentz L, Lorand L. Effects of the calcium-mediated enzymatic cross-linking of membrane proteins on cellular deformability. J Membr Biol 1981;61:75-80.
27. Kiese M. Methemoglobinemia: a comprehensive treatise. Cleveland, OH (USA): CRC Press; 1974.
28. Glader BE, Conrad ME. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS. J Lab Clin Med 1973;81:267-72.
29. Smith RP, Olson MV. Drug-induced methemoglobinemia. Semin Hematol 1973;10:253-68.
30. Singh H, Purnell E. Hemolytic potential of structurally related aniline halogenated hydroxylamines. J Environ Pathol Toxicol Oncol 2005;24:67-76.
31. International Committee for Standardization in Hematology. Recommended methods for radioisotope red cell survival studies. Blood 1971;38:378-86.
32. von Jagow R, Kiese M, Renner G. Urinary excretion of N-hydroxyl derivatives of some aromatic amines by rabbits, guinea pigs, and dogs. Biochem Pharmacol 1966;15:1899-910.
33. Kiese M. The biochemical production of ferrihemoglobinforming derivatives from aromatic amines, and mechanisms of ferrihemoglobinemia formation. Pharmacol Rev 1966:18;1091-161.
34. Eyer P, Kampffmeyer H, Maister H. Rösch-Oehme Biotransformation of nitrosobenzene, phenylhydroxylamine, and aniline in the isolated perfused rat liver. Xenobiotica 1980;10:499-516.
35. Khan MF, Kaphalia BS, Boor PJ, Ansari GAS. Subchronic toxicity of aniline hydrochloride in rats. Toxicol Lett 1993;24:368-74.
36. Valentovic MA, Rogers BA, Meadows MK, Conner JT, Williams E, Suk Kil Hong, Rankin GO. Characterization of methemoglobin formation induced by 3, 5-dichloroanilin, 4-amino-2, 6-dichlorophenoland3, 5- dichlorophenylhydroxylamine. Toxicology 1997;118:23-36.
37. McLean S, Starmer GA, Thomas J. Methemoglobin formation by aromatic amines. J Pharm Pharmacol 1969;21:441-50.
38. Kiese M, Renner G. The isolation of p-chloronitrosobenzene from the blood of dogs injected with p-chloroaniline. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 1963;246:163-74.
39. Williams JR, Challis FE. Methylene blue as an antidote for aniline dye poisoning. Case report with confirmatory experimental study. J Clin Med 1933;19:166.
40. Hughes JP, Treon JF. Erythrocytic inclusion bodies in the blood of chemical workers. AMA Arch Ind Health 1954;10:192.
41. Murayama M. The combining power of normal human hemoglobin for nitrosobenzene. J Biol Chem 1960;235:1024-8.
42. Eyer P. Reactions of nitrosobenzene with reduced glutathione. Chem Biol Interact 1979;24:227-39.
43. Yawata Y, Rinsho N. Integral proteins of red cell membranes: their genetic and phenotypic expressions. Jap J Clin Med 1996;54:2348-63.
44. Ivanov VP. The contribution of genetic and eniviornmental factors to quantitative variability of erythrocyte membrane proteins in primary hypotension. Ann Hum Genet 2005;69:25-35.
45. Palek J, Lux SE. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin Hematol 1983;20:189-224.